A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer

This publication has 17 references indexed in Scilit:

• Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice
  European Journal Of Cancer, 1995
• Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
  European Journal Of Cancer, 1994
• Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial
  JNCI Journal of the National Cancer Institute, 1994
• Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
  European Journal Of Cancer, 1993
• Diurnal variation in labelling index in human buccal epithelium
  Archives of Oral Biology, 1993
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
  Cancer, 1992
• Circadian rhythm of cellular proliferation in the human rectal mucosa
  Gastroenterology, 1991
• Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer.
  Journal of Clinical Oncology, 1989
• Effect of Biological Time on the Determination of the LD50 of 5-Fluorouracil in Mice
  Pharmacology, 1984